MAPT and type 2 diabetes mellitus: Possible explanations from animal studies include the association between diabetes, advanced glycation end products and tau phosphorylation (Kong et al., 2020), hyperglycaemia‐mediated tau cleavage (Kim et al., 2009) and the activation of glycogen synthase kinase 3β in type 2 diabetes (Kim et al., 2012).